Literature DB >> 27796633

The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience.

Sreedevi Thamarasseril1, Taft Bhuket1, Chuck Chan1, Benny Liu1, Robert J Wong2.   

Abstract

Colorectal cancer (CRC) is a leading cause of cancer-related deaths in the United States. Delays in access to colonoscopy following positive fecal immunochemical test (FIT) contribute to increased CRC incidence and mortality. To evaluate intervals from positive FIT result to receipt of colonoscopy among underserved safety-net populations. We retrospectively evaluated all average CRC risk adults who had positive FIT results from 2012 to 2015 at an ethnically diverse safety-net hospital system. Interval from positive FIT to receipt of colonoscopy was evaluated with Kaplan Meier methods and multivariate Cox proportional hazards models. Among 467 patients with positive FIT (48.4 % men, 39.5 % black, 22.5 % white, 17.4 % Asian, 9.7 % Hispanic, mean age 59.5 ± 9.8 years), mean time from positive FIT to receipt of colonoscopy was 220.5 days (SD 158.5). Compared to men, there was a trend towards longer time from FIT positive to colonoscopy among women (237.1 vs. 198.7 days, p = 0.07). No race/ethnicity-specific disparities in time to colonoscopy were observed. Compared to 2012-2013, there was a 27.2 % reduction in time from FIT positive to colonoscopy in 2014-2015 (173.9 vs. 238.8 days, p < 0.01). Among patients undergoing colonoscopy, 46.3 % had adenomatous polyps, 27.4 % had high risk adenomatous polyps, and 5.6 % had CRC. Among an ethnically diverse safety-net hospital system, improvements in access to colonoscopy after positive FIT were observed. However, patients still waited nearly 6 months from time of positive FIT to undergoing colonoscopy. Delays in receipt of colonoscopy are complex and reflect system-level and individual patient-level barriers.

Entities:  

Keywords:  Access to care; Colon cancer; Colonoscopy; Safety-net; Screening

Mesh:

Year:  2017        PMID: 27796633     DOI: 10.1007/s10900-016-0287-2

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  21 in total

1.  Determinants of racial/ethnic colorectal cancer screening disparities.

Authors:  Anthony F Jerant; Joshua J Fenton; Peter Franks
Journal:  Arch Intern Med       Date:  2008-06-23

2.  Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices.

Authors:  Adriano Correia; Linda Rabeneck; Nancy N Baxter; Lawrence F Paszat; Rinku Sutradhar; Lingsong Yun; Jill Tinmouth
Journal:  Prev Med       Date:  2015-04-18       Impact factor: 4.018

3.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.

Authors:  Amy B Knudsen; Ann G Zauber; Carolyn M Rutter; Steffie K Naber; V Paul Doria-Rose; Chester Pabiniak; Colden Johanson; Sara E Fischer; Iris Lansdorp-Vogelaar; Karen M Kuntz
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

4.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

5.  Improving the follow-up of positive hemoccult screening tests: an electronic intervention.

Authors:  Linda L Humphrey; Jackilen Shannon; Melissa R Partin; Jean O'Malley; Zunqiu Chen; Mark Helfand
Journal:  J Gen Intern Med       Date:  2011-02-15       Impact factor: 5.128

6.  Treatment delays of colon cancer in a safety-net hospital system.

Authors:  Stefanos G Millas; Zeinab M Alawadi; Curtis J Wray; Eric J Silberfein; Richard J Escamilla; Burzeen E Karanjawala; Tien C Ko; Lillian S Kao
Journal:  J Surg Res       Date:  2015-04-01       Impact factor: 2.192

7.  Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.

Authors:  Samir Gupta; Ethan A Halm; Don C Rockey; Marcia Hammons; Mark Koch; Elizabeth Carter; Luisa Valdez; Liyue Tong; Chul Ahn; Michael Kashner; Keith Argenbright; Jasmin Tiro; Zhuo Geng; Sandi Pruitt; Celette Sugg Skinner
Journal:  JAMA Intern Med       Date:  2013-10-14       Impact factor: 21.873

8.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

9.  Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.

Authors:  Reinier G S Meester; Ann G Zauber; Chyke A Doubeni; Christopher D Jensen; Virginia P Quinn; Mark Helfand; Jason A Dominitz; Theodore R Levin; Douglas A Corley; Iris Lansdorp-Vogelaar
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-19       Impact factor: 11.382

10.  Racial/Ethnic Variations in Colorectal Cancer Screening Self-Efficacy, Fatalism and Risk Perception in a Safety-Net Clinic Population: Implications for Tailored Interventions.

Authors:  Cy Lumpkins; P Cupertino; K Young; C Daley; Hw Yeh; Ka Greiner
Journal:  J Community Med Health Educ       Date:  2013-01-25
View more
  9 in total

1.  Importance of Age-Specific Insurer Perspective on Lifetime Cost Effectiveness of Colorectal Cancer Screening.

Authors:  Audrey H Calderwood
Journal:  Am J Gastroenterol       Date:  2018-10-29       Impact factor: 10.864

2.  Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.

Authors:  Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

3.  Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.

Authors:  Balambal Bharti; Folasade Fola Popoola May; Jesse Nodora; María Elena Martínez; Karina Moyano; Shauntay L Davis; Christian B Ramers; Felipe Garcia-Bigley; Shawne O'Connell; Kevin Ronan; Melissa Barajas; Sheree Gordon; Giselle Diaz; Evelyn Ceja; Meghan Powers; Elva M Arredondo; Samir Gupta
Journal:  Cancer       Date:  2019-09-03       Impact factor: 6.860

4.  Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.

Authors:  Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone
Journal:  CA Cancer J Clin       Date:  2020-06-25       Impact factor: 286.130

5.  Faecal immunochemical testing implementation to increase colorectal cancer screening in primary care.

Authors:  Smita Bakhai; Gaurav Ahluwalia; Naren Nallapeta; Amanpreet Mangat; Jessica L Reynolds
Journal:  BMJ Open Qual       Date:  2018-10-25

6.  Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.

Authors:  Revital Azulay; Liora Valinsky; Fabienne Hershkowitz; Racheli Magnezi
Journal:  JMIR Mhealth Uhealth       Date:  2019-02-05       Impact factor: 4.773

7.  Impact of COVID-19 on colorectal cancer disparities and the way forward.

Authors:  Sophie Balzora; Rachel B Issaka; Adjoa Anyane-Yeboa; Darrell M Gray; Folasade P May
Journal:  Gastrointest Endosc       Date:  2020-06-20       Impact factor: 9.427

8.  CRC Screening Results: Patient Comprehension and Follow-up.

Authors:  Revital Azulay; Liora Valinsky; Fabienne Hershkowitz; Racheli Magnezi
Journal:  Cancer Control       Date:  2019 Jan-Dec       Impact factor: 3.302

9.  Implementing a multilevel intervention to accelerate colorectal cancer screening and follow-up in federally qualified health centers using a stepped wedge design: a study protocol.

Authors:  Karen Kim; Blasé Polite; Donald Hedeker; David Liebovitz; Fornessa Randal; Manasi Jayaprakash; Michael Quinn; Sang Mee Lee; Helen Lam
Journal:  Implement Sci       Date:  2020-10-29       Impact factor: 7.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.